First-in-human Administration of a Live-Attenuated RSV Vaccine Lacking the G-protein Assessing Safety, Tolerability, Shedding and Immunogenicity: a Randomized Controlled Trial
VACCINE(2020)
Key words
Respiratory Syncytial Virus,Live-attenuated vaccine,phase I trial,Safety,Immunogenicity,Intranasal
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined